These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 22022624

  • 1. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
    Mendenhall M, Russell A, Smee DF, Hall JO, Skirpstunas R, Furuta Y, Gowen BB.
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624
    [Abstract] [Full Text] [Related]

  • 2. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, Tigabu B, Hill TE, Yun T, Pietzsch C, Furuta Y, Freiberg AN.
    PLoS Negl Trop Dis; 2013 Oct; 7(12):e2614. PubMed ID: 24386500
    [Abstract] [Full Text] [Related]

  • 3. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Gowen BB, Westover JB, Sefing EJ, Van Wettere AJ, Bailey KW, Wandersee L, Komeno T, Furuta Y.
    Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425
    [Abstract] [Full Text] [Related]

  • 4. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung KH, Dagley A, Wandersee L, Downs B, Smee DF, Furuta Y, Bray M, Gowen BB.
    Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
    [Abstract] [Full Text] [Related]

  • 5. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.
    Sci Rep; 2015 Oct 12; 5():14775. PubMed ID: 26456301
    [Abstract] [Full Text] [Related]

  • 6. Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
    Westover JB, Naik S, Bailey KW, Wandersee L, Gantla VR, Hickerson BT, McCormack K, Henkel G, Gowen BB.
    Antiviral Res; 2022 Dec 12; 208():105444. PubMed ID: 36243175
    [Abstract] [Full Text] [Related]

  • 7. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
    Hickerson BT, Westover JB, Wang Z, Lee YM, Gowen BB.
    J Virol; 2020 Jan 31; 94(4):. PubMed ID: 31748396
    [Abstract] [Full Text] [Related]

  • 8. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW, Haddock E, Meade-White K, Williamson B, Hanley PW, Rosenke K, Komeno T, Furuta Y, Gowen BB, Feldmann H.
    Antiviral Res; 2018 Sep 31; 157():18-26. PubMed ID: 29936152
    [Abstract] [Full Text] [Related]

  • 9. Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever.
    Lan S, Shieh WJ, Huang Q, Zaki SR, Liang Y, Ly H.
    Virulence; 2020 Dec 31; 11(1):1131-1141. PubMed ID: 32799623
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers.
    Lan S, McLay Schelde L, Wang J, Kumar N, Ly H, Liang Y.
    J Virol; 2009 Jul 31; 83(13):6357-62. PubMed ID: 19386714
    [Abstract] [Full Text] [Related]

  • 14. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
    Mendenhall M, Russell A, Juelich T, Messina EL, Smee DF, Freiberg AN, Holbrook MR, Furuta Y, de la Torre JC, Nunberg JH, Gowen BB.
    Antimicrob Agents Chemother; 2011 Feb 31; 55(2):782-7. PubMed ID: 21115797
    [Abstract] [Full Text] [Related]

  • 15. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.
    Gowen BB, Sefing EJ, Westover JB, Smee DF, Hagloch J, Furuta Y, Hall JO.
    Antiviral Res; 2015 Sep 31; 121():132-7. PubMed ID: 26186980
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.
    Huang Q, Shao J, Lan S, Zhou Y, Xing J, Dong C, Liang Y, Ly H.
    J Virol; 2015 Jul 31; 89(13):6595-607. PubMed ID: 25878103
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
    Shao J, Liu X, Ly H, Liang Y.
    J Virol; 2016 Nov 15; 90(22):10390-10397. PubMed ID: 27630230
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L, Rieger T, Lüdtke A, Ruibal P, Wurr S, Pallasch E, Bockholt S, Krasemann S, Muñoz-Fontela C, Günther S.
    J Infect Dis; 2016 Mar 15; 213(6):934-8. PubMed ID: 26531247
    [Abstract] [Full Text] [Related]

  • 19. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW.
    J Virol; 2016 Jan 20; 90(7):3515-29. PubMed ID: 26792737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.